Jan 10, 2026
How long do adenoviral vector vaccines typically persist in human tissues in published pharmacokinetic studies?
Published pharmacology and immunology studies show replication-defective adenoviral vector genomes commonly persist at low levels in tissues—most consistently at the injection site (muscle), in liver ...